Feedback / Questions
Exemptia (adalimumab biosimilar) - Zydus Cadila
"Cadila Launches Cadalimab (biosimilar, adalimumab) in India @Cadila_Pharma https://t.co/bGst0nEaoI"
(@Pharmashot)
Aug 31, 2020
Biosimilar launch
https://twitter.com/Pharmashot/status/1300381532553535488
Aug 31, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious